![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](bt2330contents.gif)
Acta Cryst. (2007). E63, m1770-m1771 [ doi:10.1107/S160053680701642X ]
-2-hydroxybenzoato-
2O:O')bis[(2,2'-bipyridine-
2N,N')bis(2-hydroxybenzoato-
2O,O')bismuth(III)]Abstract: The structure of the title compound, [Bi2(C7H5O3)6(C10H8N2)2], consists of centrosymmetric dimeric units in which salicylate ligands bridge two metal centres. The Bi atom is eight-coordinated, with Bi-O and Bi-N bond lengths in the ranges 2.377 (3)-3.044 (3) and 2.387 (3)-2.511 (3) Å, respectively. Each of the salicylate ligands shows an intramolecular hydrogen bond.
Online 31 May 2007
Copyright © International Union of Crystallography
IUCr Webmaster